# Keith Flaherty

ตอนพอดคาสต์ยอดนิยม
อัปเดตแล้ว:

Melanoma is Becoming Easier to Treat

Melanoma used to be really scary! Leading cancer researcher Keith Flaherty tells us how melanoma is actually becoming easier to treat. Keith has been working in cancer research for over 22 years, from UPenn to Mass General and Harvard Medical School. He has been one of the pioneers of immunotherapi…

127. Immuno-oncology landscape, Keith Flaherty, Dir. of Clin. Research, Mass General Cancer Center

Synopsis: Keith Flaherty is the Director of Clinical Research at Mass General Cancer Center and a Professor of Medicine at Harvard Medical School. Dr. Flaherty is a medical oncologist and has worked in the field for 22 years, during which he has founded seven biotech companies. He joins Rahul for …

#13 - Latest Cancer Research

Joined by Dr. Keith Flaherty from Harvard Cancer Center to discuss the following topics.   Dr. Flaherty background  Molecular understanding of cancer & its impact on cancer types Screening/early detection Assistance of AI What is within patient’s control?  Impact on families, faith,…

#267 ‒ The latest in cancer therapeutics, diagnostics, and early detection | Keith Flaherty, M.D.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Keith Flaherty is the director of clinical research at the Massachusetts General Hospital Cancer Center and a previous guest on The Drive. In this episode, Keith…

Episode 39: Dr. Keith Flaherty, Director of Clinical Research at Massachusetts General Hospital Cancer Center

"Technologies have changed enormously in terms of how we can basically procure, preserve, and then interrogate a tumor specimen...like effectively in real time, like a living cancer specimen." - Dr. Keith Flaherty, Director of Clinical Research at Massachusetts General Hospital Cancer Center, Profe…

75: Hallam-ICS President & CEO, Keith Flaherty

Keith Flaherty is the CEO and President of Hallam-ICS, a company founded in 1981 that specializes in MEP (mechanical, electrical, and plumbing) consulting, industrial automation, electrical safety, and commissioning/validation services for various sectors, including life sciences, semiconductors, f…

How Honest and Strategic Messaging Led to Rapid Growth for Engineering Firm Hallam-ICS

Engineering firm Hallam-ICS has sustained growth over the last decade, crediting honest company culture, inbound marketing in niche service areas, and evolving brand messaging as the reason for their success. We talk to the president and CEO, Keith Flaherty on the latest episode of Content Marketin…

Episode: 74 - Keith Flaherty, President-Elect of AACR, on Public and Private Collabs, AI Optimism, and More

June 10, 2025 | In this bonus episode of The Chain, Daniel Chen, MD, PhD, founder and CEO of Synthetic Design Lab, returns for the Science Commune segment and speaks with Keith Flaherty, MD, FAACR, professor of Medicine of Harvard Medical School and president-elect of AACR. They discuss Flaherty’s …

Wafik S. El-Deiry Chairs 2025 WIN Symposium in Collaboration with APM in Philadelphia

BUFFALO, NY - October 1, 2025 – Oncotarget is proud to announce that its Editor-in-Chief, Wafik S. El-Deiry, MD, PhD, FACP, will chair the WIN Symposium as the Oncology Track of the Advancing Precision Medicine (APM) Annual Conference held October 3–4, 2025, at the Pennsylvania Convention Center in…

How to Accelerate the Future of Oncology with Keith Flaherty, President of the AACR

· ถอดเสียง
What happens when a world-class biologist decides that academic research isn't moving fast enough for patients? Dr. Keith Flaherty is a physician, scientist, and founder who obsesses over the "wiring of cells". As the Director of Clinical Research at the Mass General Hospital Cancer Center and a Pr…